Form D · Other Health Care
Groove Biopharma Corp
Seattle, WA · CIK 0001443563
Offering snapshot reported Dec 20, 2011 · SEC filing
- Reported sold
- $4.5M Offering amount: $6M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 7, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 20, 2011 | Initial | $4,499,999 | No comparison | 7 | SEC filing |
| Apr 28, 2010 | Initial | $3,900,000 | No comparison | 7 | SEC filing |
| Aug 15, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-170387
Source: Form D, filed Dec 20, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Atwood | Director |
| Steven Gillis | Director |
| Merl F. Hoekstra | Director |
| Thong Le | Director |
| Lindsay Rayle | Executive |
| David Schubert | Executive |
| Chad Waite | Director |
| Carl Weissman | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1616 Eastlake Avenue E., Suite 202
Seattle, WA, 98102
Seattle, WA, 98102